EFFECTS OF CHD PREVENTION ON LIPOPROTEIN SUBCLASSES
EFFECTS OF CHD PREVENTION ON LIPOPROTEIN SUBCLASSES
批准号:
2225901
负责人:
PAUL T WILLIAMS
金额:
$8.3万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-05-01 至 1994-12-31
关键词:
adipose tissue alcoholic beverage consumption angiography antihyperlipoproteinemic agent blood glucose body weight caffeine cardiovascular disorder chemotherapy cardiovascular disorder epidemiology cardiovascular disorder prevention clinical trials clofibrate colestipol coronary artery coronary disorder denaturing gradient gel electrophoresis diet therapy dietary carbohydrates dietary lipid disease /disorder proneness /risk fasting high density lipoproteins human subject human therapy evaluation information systems insulin lifestyle lovastatin male marine animal oil nicotinate
中文摘要
斯坦福大学冠心病风险干预项目是一项为期四年的
一项随机临床试验表明,
生活方式改变和降脂药物显著减少
冠状动脉最小直径狭窄率
119例患者与127例患者的血管造影可见病变节段
接受常规医生护理的对照组。 与此同时,
在一项试验中,罗纳德克劳斯博士测量了高密度脂蛋白(HDL)
亚类的梯度凝胶电泳。 HDL可分为两种
HDL 2和三个HDL 3亚类,通过其估计值近似
颗粒直径:HDL 3c(7.2-7.8 nm)、HDL 3b(7.8-8.2 nm)、HDL 3a(8.2-8.2 nm)
8.8 HDL2a(8.8-9.7 nm)和HDL2b(9.7-12.9 nm)。 HDL-
分布也可以通过颗粒的直径来表征。
主峰,其可位于HDL 3b或HDL 3a区间。
病例对照和血管造影研究表明,
当HDL 2b相对于HDL 3c和HDL 3b降低时,疾病风险增加
我们的目的是评估HDL亚类对冠状动脉粥样硬化的影响,
疾病进展,并确定影响HDL亚类的因素
在基线和随时间推移。 将审查的具体问题是:
1. 风险降低计划是否改变了特定的HDL亚类,
与对照组相比,?
2. 高密度脂蛋白梯度凝胶曲线是否表征了男性最有可能
从多因素风险降低中获益?
3. HDL亚类是否在降低HDL水平的患者中显著改变?
脂肪摄入量,减少体重,或谁采取了一个或多个
以下药物:考来替泊,烟酸,氯贝特,
普罗布考、吉非贝齐、非诺贝特、洛伐他汀、瓜尔胶或鱼
油?
4. 高密度脂蛋白亚类与高密度脂蛋白血症的横断面相关性如何?
肥胖,空腹和负荷后胰岛素和葡萄糖,饮食和
基线药物?
初步分析表明:1)在试验期间,
治疗组HDL 2b升高; 2)特殊干预组HDL 2b升高最明显
有效地减少患有冠心病的受试者的冠状动脉疾病进展,
基线主要HDL峰直径低于中位数; 3)HDL-
亚类受饮食和肥胖的影响比
试验期间的药物; 4)碳水化合物,酒精和咖啡因
与基线时的特定子类相关。 数据存储在
计算机文件,除了包含在本文件中的分析外,
应用程序,未分析。 这些数据作为NIH的一部分收集
冠状动脉疾病中的血浆脂蛋白,HL-33577。
英文摘要
The Stanford Coronary Risk Intervention Project was a four-year
randomized clinical trial that showed that risk reduction through
lifestyle change and lipid-lowering medications significantly reduced
the rate of narrowing of the minimum diameter of coronary artery
segments with angiographically visible lesions in 119 patients vs. 127
controls who received usual physician care. In collaboration with this
trial, Dr. Ronald Krauss measured high-density lipoprotein (HDL)
subclasses by gradient gel electrophoresis. HDL may be divided into two
HDL2 and three HDL3 subclasses that are approximated by their estimated
particle diameters: HDL3c (7.2-7.8 nm), HDL3b (7.8-8.2 nm), HDL3a (8.2-
8.8 nm), HDL2a (8.8-9.7 nm) and HDL2b (9.7-12.9 nm). The HDL-
distribution can also be characterized by the diameter of the
predominant peak, which may lie in either the HDL3b or HDL3a interval.
Case control and angiographic studies suggest that coronary heart
disease risk is increased when HDL2b is reduced relative to HDL3c and HDL3b
Our objective is to assess the influence of HDL-subclasses with coronary
disease progression, and to identify factors influencing HDL subclasses
at baseline and over time. The specific questions to be examined are:
1. Did the risk reduction program change specific HDL subclasses as
compared to controls?
2. Did the HDL gradient gel profile characterize men most likely to
benefit from multifactor risk reduction?
3. Did HDL-subclasses change significantly in patients that reduced
fat intake, reduce body weight, or who took one or more of the
following medications: colestipol, nicotinic acid, clofibrate,
probucol, gemfibrozil, fenofibrate, lovastatin, guar gum or fish
oils?
4. What are the cross-sectional associations of HDL-subclasses with
adiposity, fasting and post-load insulin and glucose, diet and
medications at baseline?
Preliminary analyses suggest that: 1) During the trial, men in the
treatment group increased HDL2b; 2) the special intervention was most
effective in reducing coronary disease progression in subjects with a
baseline predominant HDL-peak diameter below the median; 3) HDL-
subclasses were more strongly influenced by diet and adiposity than by
drugs during the trial; 4) carbohydrates, alcohol and caffeine were
associated with specific subclasses at baseline. The data are stored in
computer files, and except for the analyses contained in this
application, are unanalyzed. These data were collected as part of NIH
grant Plasma lipoproteins in coronary artery disease, HL-33577.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gene-environment interaction vs quantile-dependent penetrance of established SNPs
-
批准号:8215959
-
项目类别:
-
资助金额:$32.88万
-
财政年份:2012
-
负责人:PAUL T WILLIAMS
-
依托单位:
Gene-environment interaction vs quantile-dependent penetrance of established SNPs
-
批准号:8436200
-
项目类别:
-
资助金额:$18.39万
-
财政年份:2012
-
负责人:PAUL T WILLIAMS
-
依托单位:
Gene-environment interaction vs quantile-dependent penetrance of established SNPs
-
批准号:8619627
-
项目类别:
-
资助金额:$4.72万
-
财政年份:2012
-
负责人:PAUL T WILLIAMS
-
依托单位:
Cross-sectional and prospective cohort data analysis of physical activity and hea
-
批准号:8089436
-
项目类别:
-
资助金额:$37.16万
-
财政年份:2009
-
负责人:PAUL T WILLIAMS
-
依托单位:
Cross-sectional and prospective cohort data analysis of physical activity and hea
-
批准号:7730126
-
项目类别:
-
资助金额:$38.23万
-
财政年份:2009
-
负责人:PAUL T WILLIAMS
-
依托单位:
Cross-sectional and prospective cohort data analysis of physical activity and hea
-
批准号:7922699
-
项目类别:
-
资助金额:$42.33万
-
财政年份:2009
-
负责人:PAUL T WILLIAMS
-
依托单位:
Health benefits of vigorous exercise in middle-aged versus older men and women
-
批准号:7589866
-
项目类别:
-
资助金额:$7.67万
-
财政年份:2009
-
负责人:PAUL T WILLIAMS
-
依托单位:
Gene-Specific Responses to Exercise in Discordant Twins
-
批准号:7037632
-
项目类别:
-
资助金额:$69.59万
-
财政年份:2004
-
负责人:PAUL T WILLIAMS
-
依托单位:
Gene-Specific Responses to Exercise in Discordant Twins
-
批准号:6887827
-
项目类别:
-
资助金额:$71.74万
-
财政年份:2004
-
负责人:PAUL T WILLIAMS
-
依托单位:
Gene-Specific Responses to Exercise in Discordant Twins
-
批准号:7238877
-
项目类别:
-
资助金额:$67.08万
-
财政年份:2004
-
负责人:PAUL T WILLIAMS
-
依托单位:
Gene-Specific Responses to Exercise in Discordant Twins
-
批准号:6776129
-
项目类别:
-
资助金额:$72.06万
-
财政年份:2004
-
负责人:PAUL T WILLIAMS
-
依托单位:
Long-Term Exercise Maintenance via Internet Support
-
批准号:6740702
-
项目类别:
-
资助金额:$50.42万
-
财政年份:2003
-
负责人:PAUL T WILLIAMS
-
依托单位:
Long-Term Exercise Maintenance via Internet Support
-
批准号:6933158
-
项目类别:
-
资助金额:$56.1万
-
财政年份:2003
-
负责人:PAUL T WILLIAMS
-
依托单位:
Long-Term Exercise Maintenance via Internet Support
-
批准号:7113826
-
项目类别:
-
资助金额:$57.5万
-
财政年份:2003
-
负责人:PAUL T WILLIAMS
-
依托单位:
Long-Term Exercise Maintenance via Internet Support
-
批准号:6804518
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2003
-
负责人:PAUL T WILLIAMS
-
依托单位:
PROSPECTIVE STUDY OF HEALTH IN RUNNERS AND WALKERS
-
批准号:6183952
-
项目类别:
-
资助金额:$58.03万
-
财政年份:1998
-
负责人:PAUL T WILLIAMS
-
依托单位:
PROSPECTIVE STUDY OF HEALTH IN RUNNERS AND WALKERS
-
批准号:6537327
-
项目类别:
-
资助金额:$65.55万
-
财政年份:1998
-
负责人:PAUL T WILLIAMS
-
依托单位:
PROSPECTIVE STUDY OF HEALTH IN RUNNERS AND WALKERS
-
批准号:6017304
-
项目类别:
-
资助金额:$56.96万
-
财政年份:1998
-
负责人:PAUL T WILLIAMS
-
依托单位:
PROSPECTIVE STUDY OF HEALTH IN RUNNERS AND WALKERS
-
批准号:6389705
-
项目类别:
-
资助金额:$57.38万
-
财政年份:1998
-
负责人:PAUL T WILLIAMS
-
依托单位:
PROSPECTIVE STUDY OF HEALTH IN RUNNERS AND WALKERS
-
批准号:2625718
-
项目类别:
-
资助金额:$52.25万
-
财政年份:1998
-
负责人:PAUL T WILLIAMS
-
依托单位:
海外基金